Clinical
Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort Study
Date Published
Ready to learn more?
Subscribe to our newsletter and book your free, 15-minute consultation with Forever Labs today.